| | | |  | | | | By Andrew Joseph Alan Handyside/Wellcome Collection States' anti-abortion laws could affect parents' attempts to avoid implanting embryos with disease-causing genetic mutations. Read More | | By Adam Feuerstein Courtesy ASCO/Scott Morgan The off-the-shelf therapy made from a special type of T cell induced complete remissions in patients with advanced B-cell lymphomas. Read More | | By Angus Chen Angus Chen/STAT Researchers said the results should force clinicians to see the racial biases that health care has both on a structural and a personal level. Read More | | Sponsor content by Astellas How do emerging biomarkers reveal more opportunities to advance care in gastric cancer? Despite recent advances, there is still a critical need to address unmet needs in gastric cancer. Recent research and molecular profiling have helped the industry better understand gastric tumors, uncovering novel biomarkers that may help identify previously undefined groups of patients, providing potential opportunities to advance care. As these new biomarkers emerge and expand patient profiles, find out more about the crucial role they may play in navigating the landscape of gastric cancer. | | By Katie Palmer Rodrigo Abd/AP Virtual programs could fill important gaps in diabetes care. But health tech companies like Virtaneed research to prove their worth. Read More | | By Damian Garde Adobe The failure of the Praxis trial casts doubt on what was meant to be a nuanced approach to the brain’s natural regulatory system. Read More | | By Dana Singiser Adobe The FDA's foot dragging on approving over-the-counter oral contraception harkens back to its delays in approving Plan B. Read More | |
No comments